Novavax (NVAX) Stock Leaps As Settlement Spurs Investor Optimism

The stock value of Novavax, Inc (NASDAQ: NVAX) had a significant increase of 22.61% in the last session, ending at $4.88. The completion of a settlement agreement led to this rise in Novavax’s stock price. The cooperation between Gavi, the Vaccine Alliance, and Novavax (NVAX) has paid off as the parties have reported that issues […]

Fundamentally Strong, Technicals Not Yet Positive: Novavax Inc. (NVAX)

On June 14, Novavax Inc. (NVAX), a biotechnology company, announced that its NVX-CoV2373 vaccine achieved 90.4% effectiveness in the third phase of the clinical trial against Coronavirus. Furthermore, this drug is 100% protective against moderate to severe diseases. Novavax plans to apply for FDA approval by the third quarter of this year. There will be […]